Increased asymmetric dimethylarginine in vitamin B12 deficient adolescents

Cardiology in the Young
Mehmet Akif DündarÇiğdem Karakükçü

Abstract

Vitamin B12 deficiency induces hyper-hyperhomocysteinemia by inhibiting intracellular methionine re-methylation. Hyper-hyperhomocysteinemia increases the risk of atherosclerosis. Asymmetric dimethylarginine is an endogenous inhibitor of nitric oxide synthase and its level elevates in cardiovascular diseases. In this study, we aimed to examine the relationship between asymmetric dimethylarginine and arterial stiffness and atherosclerosis in adolescents with vitamin B12 deficiency. A total of 88 adolescents with age ranging between 11 and 17 years of age were enrolled for this study. Among them, 50 patients had vitamin B12 deficiency 200 pg/ml. In all cases, the levels of asymmetric dimethylarginine were measured with high performance liquid chromatography method. The carotid artery intima media thickness and left ventricular mass index were measured using echocardiography. All these measurements of the study groups were compared. Both plasma levels of asymmetric dimethylarginine and carotid artery intima media thickness were significantly higher in the vitamin B12 deficiency group than in the control group. Correlation analysis showed significant negative correlation of vitamin B12 with homocysteine, asymmetric dimethylarginine,...Continue Reading

References

Jan 1, 1989·Journal of Inherited Metabolic Disease·C R Scriver
Sep 1, 1988·Journal of the American College of Cardiology·S R DanielsK E Bove
Dec 6, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·C LibettaA Dal Canton
Dec 20, 2003·Journal of the American Society of Nephrology : JASN·Carmine ZoccaliGiovanni Tripepi
Apr 21, 2004·Circulation·John P Cooke
Jun 5, 2004·Stroke; a Journal of Cerebral Circulation·Sanjana DayalSteven R Lentz
Jan 4, 2008·Circulation·Marcello TonelliUNKNOWN for the Cholesterol and Recurrent Events (CARE) Trial Investigators
Apr 11, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Julian G AyerDavid S Celermajer
Jul 15, 2009·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Rainer H BögerEdzard Schwedhelm
Oct 7, 2010·European Journal of Heart Failure·Marlieke VisserPaul A M van Leeuwen
Mar 8, 2011·Journal of the Formosan Medical Association = Taiwan Yi Zhi·You-Lin Tain, Li-Tung Huang
Mar 29, 2014·Cardiology in the Young·Rachael L CordinaDavid S Celermajer
Mar 11, 2015·Trends in Cardiovascular Medicine·David E SchmidtImo E Hoefer
May 23, 2015·American Journal of Preventive Medicine·Roman Pawlak

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.